ZA915567B - Process for the manufacture of quinoline derivatives - Google Patents

Process for the manufacture of quinoline derivatives

Info

Publication number
ZA915567B
ZA915567B ZA915567A ZA915567A ZA915567B ZA 915567 B ZA915567 B ZA 915567B ZA 915567 A ZA915567 A ZA 915567A ZA 915567 A ZA915567 A ZA 915567A ZA 915567 B ZA915567 B ZA 915567B
Authority
ZA
South Africa
Prior art keywords
manufacture
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
ZA915567A
Other languages
English (en)
Inventor
Arnold Harry Ratcliffe
Harry Ratcliffe Arnold
Emyr Glyn Williams
Glyn Williams Emyr
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA915567B publication Critical patent/ZA915567B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA915567A 1990-08-09 1991-07-16 Process for the manufacture of quinoline derivatives ZA915567B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017479A GB9017479D0 (en) 1990-08-09 1990-08-09 Process

Publications (1)

Publication Number Publication Date
ZA915567B true ZA915567B (en) 1992-07-29

Family

ID=10680406

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915567A ZA915567B (en) 1990-08-09 1991-07-16 Process for the manufacture of quinoline derivatives

Country Status (15)

Country Link
EP (1) EP0495948A1 (cs)
JP (1) JPH05501728A (cs)
KR (1) KR920702357A (cs)
CN (1) CN1058965A (cs)
AU (1) AU8309091A (cs)
CA (1) CA2047249A1 (cs)
CS (1) CS88692A3 (cs)
FI (1) FI921319L (cs)
GB (2) GB9017479D0 (cs)
HU (1) HUT60490A (cs)
IE (1) IE912406A1 (cs)
IL (1) IL98833A0 (cs)
PT (1) PT98607A (cs)
WO (1) WO1992002508A1 (cs)
ZA (1) ZA915567B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
US5484955A (en) * 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
US6608048B2 (en) 2000-03-28 2003-08-19 Wyeth Holdings Tricyclic protein kinase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
PE20160930A1 (es) 2013-09-16 2016-09-03 Astrazeneca Ab Nanoparticulas polimericas terapeuticas y metodos para su elaboracion y uso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
DE69016125T2 (de) * 1989-08-11 1995-06-01 Zeneca Ltd Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.

Also Published As

Publication number Publication date
CS88692A3 (en) 1992-10-14
FI921319A7 (fi) 1992-03-26
AU8309091A (en) 1992-03-02
JPH05501728A (ja) 1993-04-02
PT98607A (pt) 1992-06-30
GB9115250D0 (en) 1991-08-28
WO1992002508A1 (en) 1992-02-20
IL98833A0 (en) 1992-07-15
CN1058965A (zh) 1992-02-26
KR920702357A (ko) 1992-09-03
IE912406A1 (en) 1992-02-12
FI921319A0 (fi) 1992-03-26
HUT60490A (en) 1992-09-28
HU9200933D0 (en) 1992-05-28
CA2047249A1 (en) 1992-02-10
EP0495948A1 (en) 1992-07-29
GB9017479D0 (en) 1990-09-26
FI921319L (fi) 1992-03-26

Similar Documents

Publication Publication Date Title
HU913664D0 (en) Process for the production of indian- and kinoline derivatives
ZA915786B (en) Process for the manufacture of biphenylcarbonitriles
HU913595D0 (en) Process for the production of tnf-muteines
HU912005D0 (en) Process for the production of aminobenzodiazepines
ZA918636B (en) Process for the preparation of piperazine derivatives
HU913290D0 (en) Process for the production of cyuclodextrines
YU188284A (en) Process for the manufacture of quinoline derivatives
HU910151D0 (en) Process for the production of substituted 2-chloride-pyridines
HU9200933D0 (en) Process for the production of kinoline derivatives
HU904780D0 (en) Process for the production of indenoidole derivatives
HU908137D0 (en) Process for the production of carbamoil derivatives
HU913280D0 (en) Process for the production of 8-chloro-kinoline derivatives
HU910937D0 (en) Process for the production of 8-sulfamylethylene-2-amino-tetraline derivatives
HU901554D0 (en) Process for the preparation of quinoline derivatives
EP0439745A3 (en) Process for the preparation of 2-chloro-5-methyl-pyridine
ZA915396B (en) Process for the preparation of 1-hydroxymethylpyrazoles
EP0449778A3 (en) Process for the preparation of hydroxyphenylepropionates
IL97512A0 (en) Process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles
EP0444460A3 (en) Process for the preparation of acrolin
EP0481287A3 (en) Method for the production of substituted cyclohexylidenebisphenols
IL98877A0 (en) Process for the preparation of n-alkylsulfonylamino-sulfonylureas
IL100132A0 (en) Process for the production of decabromodiphenylalkane
IL94101A0 (en) Process for the production of difluorohalomethoxybenzene derivatives
ZA915630B (en) Process for the preparation of n-alkylsulfonylaminosulfonylureas
EP0459242A3 (en) Process for the preparation of phenolethers